Related Experiment Videos
Neurocardiogenic syncope in children with a normal heart
S Balaji1, P C Oslizlok, M C Allen
1South Carolina Children's Heart Center, Division of Pediatric Cardiology, Medical University of South Carolina, Charleston.
Journal of the American College of Cardiology
|March 1, 1994
Summary
Children with syncope and normal hearts often have neurocardiogenic syncope, indicated by autonomic dysfunction and beta-adrenergic hypersensitivity. Treatment with fludrocortisone, salt, and beta-blockers effectively improved symptoms in most patients.
Area of Science:
- Pediatric Cardiology
- Autonomic Nervous System Function
- Syncope Etiologies
Background:
- Syncope is a frequent clinical issue with diverse causes.
- Autonomic testing, particularly the tilt/orthostatic test, aids in diagnosing neurocardiogenic syncope.
Purpose of the Study:
- To review the investigation and management outcomes for children experiencing syncope with structurally normal hearts.
- To evaluate the effectiveness of specific treatments for neurocardiogenic syncope in pediatric patients.
Main Methods:
- Reviewed 162 children (ages 1-20) with syncope, analyzing case notes and autonomic test results.
- Autonomic testing included orthostatic maneuvers, carotid sinus massage, diving reflex, Valsalva maneuver, and drug responses (isoproterenol, phenylephrine).
- Measured serum epinephrine and norepinephrine levels during orthostatic testing; initiated treatment with fludrocortisone/salt and beta-blockers as needed.
Main Results:
- Orthostatic testing confirmed neurocardiogenic syncope in 62% of patients.
- Neurocardiogenic syncope patients were older, more female, and showed distinct autonomic responses (e.g., altered norepinephrine/epinephrine levels, beta-adrenergic hypersensitivity).
- Treatment led to symptom resolution or improvement in 82% of patients receiving fludrocortisone/salt and 80% receiving beta-blockers.
Conclusions:
- Pediatric patients with orthostatic test-proven neurocardiogenic syncope exhibit autonomic dysfunction and beta-adrenergic hypersensitivity.
- The established treatment protocol effectively ameliorated symptoms in the majority of affected children.
- Findings support the diagnostic utility of autonomic testing and targeted therapy for pediatric syncope.